Inventor · disambiguated record
Philippe Moingeon
Also filed as: MOINGEON PHILIPPE
17 granted patents·7 pending applications·25 citations·filing 2000–2017
89Inventor score
Top patents by PatentIndex Score
24 records- 0188US8017590B1Method of inducing and/or enhancing an immune response to tumor antigensSANOFI PASTEUR LTD·Filed 2000·Granted Sep 13, 2011·16 cites·31 claims
- 0275US7851212B2Immunogenic polypeptides encoded by MAGE minigenes and uses thereofSANOFI PASTEUR LTD·Filed 2001·Granted Dec 14, 2010·3 cites·14 claims
- 0368US8632993B2Method for grass species identificationMOINGEON PHILIPPE·Filed 2010·Granted Jan 21, 2014·2 cites·4 claims
- 0461US9480748B2Mucoadhesive particulate formulation for inducing antigen-specific immune toleranceSTALLERGENES SA·Filed 2013·Granted Nov 1, 2016·1 cites·10 claims
- 0559US10101341B2Biomarkers of immunotherapy efficacyBODO VERONIQUE·Filed 2012·Granted Oct 16, 2018·2 cites·16 claims
- 0659US9187568B2Use of IgG1 immunoglobulins and/or ligands of the CD32 receptor for treating inflammatory diseases and manifestations via the mucosal routeBATARD THIERRY·Filed 2010·Granted Nov 17, 2015·1 cites·15 claims
- 0758US8257717B2Immunogenic polypeptides encoded by MAGE minigenes and uses thereofBERINSTEIN NEIL·Filed 2010·Granted Sep 4, 2012·0 cites·17 claims
- 0858US2010260807A1Methods of Inducing and/or Enhancing an Immune Response To Tumor AntigensBERINSTEIN NEIL·Filed 2009·Application pending·0 cites
- 0957US2011319480A1Method of Inducing and/or Enhancing an Immune Response to Tumor AntigensBERINSTEIN NEIL·Filed 2011·Application pending·0 cites
- 1056US11027010B2Reduction of in vitro genotoxicity of pollen extracts by removal of flavonoidsSTALLERGENES·Filed 2017·Granted Jun 8, 2021·0 cites·4 claims
- 1150US2013216563A1Immunogenic Polypeptides Encoded by MAGE Minigenes and Uses ThereofBERINSTEIN NEIL·Filed 2012·Application pending·0 cites
- 1249US2011150987A1Mucoadhesive particulate formulation for inducing antigen-specific immune toleranceSTALLERGENES SA·Filed 2009·Application pending·0 cites
- 1348US9555102B2Compositions for antigen-specific induction of toleranceMOINGEON PHILIPPE·Filed 2006·Granted Jan 31, 2017·0 cites·26 claims
- 1445US9822185B2Use of IGG1 immunoglobulins and/or ligands of the CD32 receptor for treating inflammatory diseases and incidents via the mucosaSTALLERGENES SA·Filed 2015·Granted Nov 21, 2017·0 cites·4 claims
- 1544US10610586B2Compositions for antigen-specific induction of toleranceSTALLERGENES·Filed 2016·Granted Apr 7, 2020·0 cites·16 claims
- 1643US10190166B2Methods for identifying dendritic cell subsets, for determining if a patient is developing a regulatory or an effector immune response, and for determining response to immunotherapyMOINGEON PHILIPPE·Filed 2012·Granted Jan 29, 2019·0 cites·4 claims
- 1743US9795644B2Reduction of in vitro genotoxicity of pollen extracts by removal of flavonoidsMOINGEON PHILIPPE·Filed 2010·Granted Oct 24, 2017·0 cites·8 claims
- 1839US11028441B2IL-10 as a predictive biomarker of responsiveness to house dust mite allergen immunotherapySTALLERGENES·Filed 2017·Granted Jun 8, 2021·0 cites·4 claims
- 1937US11015221B2Markers of immune responseSTALLERGENES·Filed 2015·Granted May 25, 2021·0 cites·3 claims
- 2036US2017157240A1Composition of allergen extracts having reduced toxicity and method of production thereofSTALLERGENES·Filed 2015·Application pending·0 cites
- 2134US2016367631A1C1q as a therapeutic agent of allergy and/or asthmaSTALLERGENES·Filed 2014·Application pending·0 cites
- 2233US10884002B2Sialylated fetuin-A as a marker of immunotherapy efficacySTALLERGENES·Filed 2015·Granted Jan 5, 2021·0 cites·8 claims
- 2333US2008274059A1Mite fusion proteinsSTALLERGENES SA·Filed 2007·Application pending·0 cites
- 2422US9868770B2Recombinant Der P 2 expressed in Pichia Pastoris as a “natural-like” allergen for immunotherapy and diagnostic purposesBORDAS VÉRONIQUE·Filed 2011·Granted Jan 16, 2018·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Philippe Moingeon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →